Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 12/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 12/20 | 0.41 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.41 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.41 |
| ▸ | EGLN2 | Q96KS0 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7447049 | 0.88 | CA1 (0.39) | CA1CA2ITGB3ITGA2BKDM4E | |
| Trifluoroacetic Acid SCHEMBL7372144 | 0.84 | CA1 (0.36) | CA1CA2ITGB3ITGA2BKDM4E | |
| SCHEMBL6437619 | 0.80 | PTPRC (0.42) | KDM4E | |
| SCHEMBL7369532 | 0.79 | ITGB3 (0.46) | ITGB3ITGA2B | |
| SCHEMBL7378246 | 0.77 | CA1 (0.42) | CA1CA2ITGB3ITGA2BCSNK2A2 | |
| Trifluoroacetic Acid SCHEMBL7377943 | 0.77 | TMPRSS15 (0.44) | CA1CA2ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL7374048 | 0.75 | PLAU (0.45) | KDM4EALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL7368775 | 0.74 | ITGB3 (0.44) | ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL7450905 | 0.73 | CA2 (0.44) | CA1CA2 | |
| SCHEMBL6437334 | 0.71 | ROCK2 (0.49) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1242120-A2 | COMBINATIONS OF GROWTH FACTORS AND I:UPA OR I:MMP FOR THE TREATMENT OF DAMAGED TISSUE | Pfizer Limited (GB) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001049309-A2 | COMBINATIONS OF GROWTH FACTORS AND I: UPA OR I: MMP FOR THE TREATMENT OF DAMAGED TISSUE | PFIZER LIMITED (GB) | 2001-07-12 | — | — | WO | disclosed |
| EP-1077945-A1 | ISOQUINOLINES AS UROKINASE INHIBITORS | PFIZER INC. (US) | 2001-02-28 | — | — | EP | disclosed |
| WO-2000005214-A2 | ISOQUINOLINES AS UROKINASE INHIBITORS | PFIZER INC. (US) | 2000-02-03 | — | — | WO | disclosed |